2d
Hosted on MSNBioMarin to Report Q4 Earnings: Here's What to ExpectBioMarin Pharmaceutical BMRN is scheduled to report fourth-quarter and full-year 2024 earnings on Feb. 19, after market close ...
Ramsey Rugby Club head west this weekend to take on Western Vikings in the Manx Shield at QEII High School in Peel.
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...
5d
Hosted on MSNScotiabank Initiates Coverage of Viking Therapeutics (VKTX) with Sector Outperform RecommendationFintel reports that on February 13, 2025, Scotiabank initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Sector ...
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
As previously reported, Scotiabank analyst George Farmer initiated coverage of Viking Therapeutics (VKTX) with an Outperform rating and $102 ...
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results